Discovery and synthesis of novel substituted benzocoumarins as orally active lipid modulating agents

被引：60
|
作者：
Sashidhara, Koneni V. [1 ]
Kumar, Manoj [1 ]
Modukuri, Ram K. [1 ]
Srivastava, Anuj [2 ]
Puri, Anju [2 ]
机构：
[1] Cent Drug Res Inst CSIR CDRI, Med & Proc Chem Div, Lucknow 226001, Uttar Pradesh, India
[2] Cent Drug Res Inst CSIR CDRI, Div Biochem, Lucknow 226001, Uttar Pradesh, India
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2011年 / 21卷 / 22期
关键词：
Synthesis; Benzocoumarin; Statins; Antidyslipidemic; LOW-DENSITY-LIPOPROTEIN; DERIVATIVES;
D O I：
10.1016/j.bmcl.2011.09.053
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The synthesis of a series of benzocoumarin keto-enamine schiff bases is reported. The novel compounds were evaluated for their antihyperlipidemic activity in the hyperlipidemic hamster model. The compound 11 at a dose of 10 mg/kg body weight significantly lowered the plasma triglyceride levels (TG) by 70%, total cholesterol (TC) by 47%, accompanied by an increase in HDL-C/TC ratio by 80% in hyperlipidemic hamsters to a greater degree than the reference drugs atorvastatin and lovastatin. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码：6709 / 6713
页数：5
相关论文
共 50 条
  • [21] Discovery of tofacitinib derivatives as orally active antitumor agents based on the scaffold hybridization strategy
    Shi, Xiao-Jing
    Wang, Shuai
    Li, Xiao-Jing
    Yuan, Xiao-Han
    Cao, Li-Juan
    Yu, Bin
    Liu, Hong-Min
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [22] Discovery and development of novel substituted monohydrazides as potent antifungal agents
    Chandrika, Nishad Thamban
    Green, Keith D.
    Spencer, Abbygail C.
    Tsodikov, Oleg V.
    Garneau-Tsodikova, Sylvie
    RSC MEDICINAL CHEMISTRY, 2023, 14 (07): : 1351 - 1361
  • [23] Synthesis and biological evaluation of orally active anti-Trypanosoma agents
    Salem, Fatma M.
    Martin, William R.
    Zhao, Xiaotong
    Sayeed, S. K. Adbus
    Ighneim, Sabreena
    Greene, Mckenna
    Mohamed, Eman
    Orahoske, Cody M.
    Zhang, Wenjing
    Li, Bibo
    Su, Bin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 107
  • [24] Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor
    Bowers, Simeon
    Truong, Anh P.
    Neitz, R. Jeffrey
    Neitzel, Martin
    Probst, Gary D.
    Hom, Roy K.
    Peterson, Brian
    Galemmo, Robert A., Jr.
    Konradi, Andrei W.
    Sham, Hing L.
    Toth, Gergley
    Pan, Hu
    Yao, Nanhua
    Artis, Dean R.
    Brigham, Elizabeth F.
    Quinn, Kevin P.
    Sauer, John-Michael
    Powell, Kyle
    Ruslim, Lany
    Ren, Zhao
    Bard, Frederique
    Yednock, Ted A.
    Griswold-Prenner, Irene
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1838 - 1843
  • [25] Discovery of novel, orally active, synthetic GPR119 agonists as potential agents for treatment of obesity and associated metabolic disorders
    Fyfe, Matthew
    Overton, Hilary
    White, Jonathan
    Jones, Robert
    Sorensen, Rikke Veggerby
    Reynet, Christine
    DIABETES, 2006, 55 : A81 - A81
  • [26] Discovery of Novel 2-Aminobenzamide Inhibitors of Heat Shock Protein 90 as Potent, Selective and Orally Active Antitumor Agents
    Huang, Kenneth H.
    Veal, James M.
    Fadden, R. Patrick
    Rice, John W.
    Eaves, Jeron
    Strachan, Jon-Paul
    Barabasz, Amy F.
    Foley, Briana E.
    Barta, Thomas E.
    Ma, Wei
    Silinski, Melanie A.
    Hu, Mei
    Partridge, Jeffrey M.
    Scott, Anisa
    DuBois, Laura G.
    Freed, Tiffany
    Steed, Paul M.
    Ommen, Andy J.
    Smith, Emilie D.
    Hughes, Philip F.
    Woodward, Angela R.
    Hanson, Gunnar J.
    McCall, W. Stephen
    Markworth, Christopher J.
    Hinkley, Lindsay
    Jenks, Matthew
    Geng, Lifeng
    Lewis, Meredith
    Otto, James
    Pronk, Bert
    Verleysen, Katleen
    Hall, Steven E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4288 - 4305
  • [27] Discovery of a novel class of orally active CGRP receptor antagonists for the treatment of migraine
    Bell, Ian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [28] Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
    Brand, Stephen
    Cleghorn, Laura A. T.
    McElroy, Stuart P.
    Robinson, David A.
    Smith, Victoria C.
    Hallyburton, Irene
    Harrison, Justin R.
    Norcross, Neil R.
    Spinks, Daniel
    Bayliss, Tracy
    Norval, Suzanne
    Stojanovski, Laste
    Torrie, Leah S.
    Frearson, Julie A.
    Brenk, Ruth
    Fairlamb, Alan H.
    Ferguson, Michael A. J.
    Read, Kevin D.
    Wyatt, Paul G.
    Gilbert, Ian H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 140 - 152
  • [29] DISCOVERY OF A NOVEL CLASS OF ORALLY ACTIVE, NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS
    DE, B
    WINN, M
    ZYDOWSKY, TM
    KERKMAN, DJ
    DEBERNARDIS, JF
    LEE, J
    BUCKNER, S
    WARNER, R
    BRUNE, M
    HANCOCK, A
    OPGENORTH, T
    MARSH, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) : 3714 - 3717
  • [30] Discovery of novel orally active ureido NPYY5 receptor antagonists
    Li, Guoqing
    Stamford, Andrew W.
    Huang, Ying
    Cheng, Kuo-Chi
    Cook, John
    Farley, Constance
    Gao, Jun
    Ghibaudi, Lorraine
    Greenlee, William J.
    Guzzi, Mario
    van Heek, Margaret
    Hwa, Joyce J.
    Kelly, Joe
    Mullins, Deborra
    Parker, Eric M.
    Wainhaus, Sam
    Zhang, Xiaoping
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 1146 - 1150
12345